Home > Products > CD19 & CD3 > Recombinant Anti-CD19 x Anti-CD3 Bispecific Antibody (Bibody)

Recombinant Anti-CD19 x Anti-CD3 Bispecific Antibody (Bibody)  (CAT#: BIBD-041)

Recombinant Anti-CD19 x Anti-CD3 Bispecific Antibody (Bibody) is a Fab-scFv format that uses heterodimeric Fab as a scaffold, and a scFv region linked to one of its heavy (Fd) or light (L) chain. The scFv of the anti-CD19 specificity is fused to the anti-CD19 heavy or light chain of the Fab. This BsAb can retarget T cells to tumor cells. It is designed for the research of B cell lymphoma; Follicular lymphoma; Leukemia therapy.
Datasheet INQUIRY

Specifications

Targets
CD19 & CD3
Type
Bibody
Species Reactivity
Human
Application
FuncS; Promising therapeutic agent
Related Disease
B cell lymphoma; Follicular lymphoma; Leukemia

Targets

Target 1
CD19
Gene ID
UniProt ID
Alternative Names
CD19; CD19 molecule; Cluster of differentiation 19; B4; CVID3; B-lymphocyte antigen CD19; differentiation antigen CD19; T-cell surface antigen Leu-12; B-lymphocyte surface antigen B4
Target 2
CD3
Gene ID
UniProt ID
Alternative Names
CD3E; CD3e molecule; Cluster of differentiation 3; CD3e molecule, epsilon (CD3-TCR complex); T3E; TCRE; IMD18; T-cell surface glycoprotein CD3 epsilon chain; CD3-epsilon; T-cell surface antigen T3/Leu-4 epsilon chain; CD3e antigen, epsilon polypeptide (TiT3 complex); T-cell antigen receptor complex, epsilon subunit of T3
Our products and services are for research use only, and not for use in diagnostic or therapeutic procedures.
Online Inquiry

Related products of "CD19 & CD3"

Customer Reviews and Q&As

There are currently no customer reviews or questions for Recombinant Anti-CD19 x Anti-CD3 Bispecific Antibody (Bibody) (BIBD-041). Click the button below to contact us or submit your feedback about this product.